John Peter Serlemitsos Md is categorized under Internal Medicine Practitioners in Crownsville, MD and active since 2011.
John Peter Serlemitsos Md was established in 2011, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Internal Medicine Practitioners business, which does work in the B2C market, and is classified as a Internal Medicine Practitioners, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact John Peter Serlemitsos at the company’s single location by writing to 2033 Penderbrooke Drive, Crownsville, Maryland MD 21032 or by phoning (410) 212-5165. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | John Peter Serlemitsos Md |
| Contact Person: | John Peter Serlemitsos |
| Address: | 2033 Penderbrooke Drive, Crownsville, Maryland 21032 |
| Phone Number: | (410) 212-5165 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2011 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Practitioners |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
John Peter Serlemitsos Md was started in 2011 to provide professional Internal Medicine Practitioners under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact John Peter Serlemitsos for inquiries that concern John Peter Serlemitsos Md by calling the company number (410) 212-5165, as your correspondence is most welcome. Additionally, the physical location of the single location of John Peter Serlemitsos Md can be found at the coordinates 39.025008,-76.631229 as well as the street address 2033 Penderbrooke Drive in Crownsville, Maryland 21032.
For its online presence, you may visit John Peter Serlemitsos Md’s website at and engage with its social media outlets through on Twitter and on Facebook.